Skip to content
Search

Latest Stories

MHRA warning: Thousands of counterfeit anti-choking devices sold across the UK

MHRA warning: Thousands of counterfeit anti-choking devices sold across the UK

People are warned that use of unbranded devices could exacerbate the situation by pushing obstructions further down into the airway passage 

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised the public to exercise caution when buying anti-choking devices online, ensuring these products are purchased from reputable sellers.


As estimated by the regulator, more than 10,000 counterfeit or unbranded anti-choking devices have been purchased by the public within the last two years through listings on online marketplaces such as Amazon and eBay, as well as drop-shipping websites.

People are cautioned that the use of such products poses a substantial risk of failure in clearing blockages and could exacerbate the situation by pushing obstructions further down into the airway passage.

Dr Alison Cave, MHRA Chief Safety Officer, said: “Buying anti-choking devices that do not have a valid UKCA or CE mark increases the risk of receiving a product which does not include appropriate instructions and is either fake or does not meet the UK’s regulatory requirements.

“These products do not meet our strict quality standards and may put your health and safety at significant risk by failing to resolve or even worsening choking incidents.”

Currently, two anti-choking device brands, LifeVac and Dechoker, have a valid UKCA or CE mark and are authorised by the MHRA to be used after Basic Life Support protocols have been attempted and proved ineffective.

According to the regulator, most counterfeit or unbranded anti-choking devices are manufactured or shipped from China. These fake products resemble the design of the LifeVac device and, in some cases, claim to be the genuine brand.

“None of the anti-choking devices registered with the MHRA are manufactured in China. Any products shipped from China should be treated with caution and disposed,” the MHRA warning said.

How to check whether the device is genuine or counterfeit?

Photos highlighting the differences between a genuine and a counterfeit anti-choking device are provided in the Device Safety Information alert released by the MHRA

Key distinctions between a genuine and counterfeit device are highlighted here.

Screenshot 2024 03 25 225140

Screenshot 2024 03 25 225234

Screenshot 2024 03 25 225308

Screenshot 2024 03 25 225407

Buyers can also contact the legal manufacturer, LifeVac, which can verify the legitimacy of a purchased product against their records of authorised distributors and product serial numbers.

However, the MHRA has not received any reports regarding adverse incidents related to anti-choking devices.

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less